CAR T Cell Therapy: A Versatile Living Drug

After seeing a dramatic increase in the development and use of immunotherapy and precision medicine over the past few decades, oncological care now embraces the start of the adoptive cell therapy (ACT) era. This impulse towards a new treatment paradigm has been led by chimeric antigen receptor (CAR)...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Rodrigo C., Monzo, Hector J., Ojala, Päivi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094630/
https://www.ncbi.nlm.nih.gov/pubmed/37047272
http://dx.doi.org/10.3390/ijms24076300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094630/
https://www.ncbi.nlm.nih.gov/pubmed/37047272
http://dx.doi.org/10.3390/ijms24076300

Ejemplares similares